Efficacy Study of Extended-Release Niacin/Lovastatin Versus Usual Care

• Status: Completed
• Trial end date: 2004-05-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to investigate the benefits of combination niacin ER/lovastatin in patients receiving standard care who are not at LDL goal per ATP III guidelines.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: In His Image
• Collaborator: Kos Pharmaceuticals
• Treatments: Dihydromevinolin; Hydroxymethylglutaryl-CoA Reductase Inhibitors; L 647318; Lovastatin; Niacin; Niacinamide; Nicotinic Acids

Criteria

Inclusion Criteria:

1. >18 years old with CAD or risk factors for CAD

2. under standard care at Family Medical Care of Tulsa

3. not at LDL goal per ATP III guidelines

Exclusion Criteria:

1. pregnancy/lactating

2. liver disease

3. allergies to statin or niacin

4. active peptic ulcer disease

5. previous treatment with combination therapy for dyslipidemia